Our vision is to create a simple and quick access channel for patients and companies in the Asia-Pacific region to obtain pharmaceutical products globally at a reasonable cost. We also provide solutions and potential partners for pharmaceutical companies wanting to expand markets to patients who suffer from rare diseases or need orphan drugs.
Founder & CEO
Ben Tsai is the founder and CEO of DaRay Trading Company, Inc. He has more than 20 years of experience in international specialty pharmaceutical trading, and is a registered pharmacist by training with a degree from the University of Texas at Austin, College of Pharmacy. His working experience includes senior management positions in both medical device and pharmaceutical companies, director of regulatory and logistic affairs in specialty distribution, director of pharmacy services, lead pharmacist and district trainer for a large chain pharmacy store.
Mr. Tsai has successfully bridged, planned and launched more than 20 orphan drugs in the Asia-Pacific region, including those for mucopolysaccharidosis and other enzyme replacement therapies, Cushing's Syndrome, Wilson's disease, X-linked hypophosphatemic rickets, inborn error of bile acid deficiency, Duchenne muscular dystrophy medications. Also in his business focus is hematology , oncology, and organ transplantation products.
HOW CAN WE HELP?
Contact us for expert information, professional advice, consultation appointments, or anything else we can provide.